Arrowhead Pharmaceuticals earnings were -$538.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ARWR earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$170.8M, up 36.3% from last quarter. For the last reported fiscal year 2023 ending Sep 30, 2023, ARWR reported annual earnings of -$205.3M, with 16.6% growth. The next ARWR earnings date is Nov 27, 2024.
Arrowhead Pharmaceuticals Earnings Reports & History FAQ
What were Arrowhead Pharmaceuticals's earnings last quarter?
On ARWR's earnings call on Invalid Date, Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q2 2024 earnings per share (EPS) of -$1.38, up 43.75% year over year. Total ARWR earnings for the quarter were -$170.79 million. In the same quarter last year, Arrowhead Pharmaceuticals's earnings per share (EPS) was -$0.96.
When does Arrowhead Pharmaceuticals report earnings?
The next ARWR earnings call is Invalid Date. Add ARWR to your watchlist to be reminded of Arrowhead Pharmaceuticals's next earnings date.
What was ARWR's earnings growth in the past year?
As of Arrowhead Pharmaceuticals's earnings date in Invalid Date, Arrowhead Pharmaceuticals's earnings has grown year over year. ARWR earnings in the past year totalled -$538.64 million.
Is Arrowhead Pharmaceuticals profitable or losing money?
As of the last Arrowhead Pharmaceuticals earnings report, Arrowhead Pharmaceuticals is currently losing money. Arrowhead Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$538.64 million, a 197.41% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.